Clinical Research Directory
Browse clinical research sites, groups, and studies.
Mifepristone vs Misoprostol
Sponsor: Montefiore Medical Center
Summary
The Investigator team hypothesizes that in a randomized trial comparing mifepristone-alone or misoprostol-alone for cervical preparation for procedural abortions at 12 to 16 weeks in hospital-based care, the proportion of patients who achieve successful cervical dilation will be different between the study groups.
Official title: Mifepristone Versus Misoprostol for Cervical Preparation Prior to Procedural Abortion at 12 to 16 Weeks' Gestation in an Academic Medical Center: a Randomized Controlled Pilot Trial
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
INTERVENTIONAL
Enrollment
94
Start Date
2024-10-31
Completion Date
2026-10
Last Updated
2025-08-13
Healthy Volunteers
Yes
Conditions
Interventions
Mifepristone
200 milligrams (mg)
Misoprostol
600 micrograms (ug)
Locations (1)
Montefiore Medical Center
The Bronx, New York, United States